The pulmonary vasculature is the exclusive target of disease in PPH, although its pathogenesis remains ... PPH associated with pulmonary arterial hypertension include collagen vascular disease ...

Researchers identified several inflammatory circulating proteins that could be useful biomarkers for predicting outcomes in ...

In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...

and pulmonary hypertension may be particularly relevant to the pathophysiology heart failure in patients with preserved ejection fraction, there is compelling rationale for extending the ...

Jones, with Novant Health, spoke with WECT about a different type of hypertension that specifically affects the lungs’ blood ...

Katrina Berry was 24 years old when she first started experiencing symptoms of pulmonary arterial hypertension (PAH), a ...

The case reported below does document the severe pulmonary hypertension existing before any therapy, the almost instantaneous reversal of this hypertension with temporary relief of obstruction and ...

Pulmonary fibrosis (PF), scarring of tissue surrounding tiny air sacs called alveoli, can result in life-threatening ...

BACKGROUND: The European Chronic Thromboembolic Pulmonary Hypertension registry (CTEPH), conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term ...

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Gossamer Bio (GOSS – Research Report) and keeping the price ...

Katrina Berry was 24 years old when she first started experiencing symptoms of pulmonary arterial hypertension (PAH), a progressive health condition that leads to reduced cardiac output and right ...